Pediatric Dermatology

In future, sensitivity tests may be performed on individual chemicals;better labeling a possibility

Contact Allergen Replacement Database helps patients avoid antigen exposurein skincare products

Suspicion remains high among parents of patients, but true food allergypresents in only one-third of cases

Kenilworth, N.J. - Clarinex, a new systemic drug for treatmentof urticaria (hives), has been approved by the Food and Drug Administration(FDA), according to Schering-Plough, the drug's manufacturer.

Mechanism action UVB treatment isinactivation of pruritogenic substancesNewOrleans - UV light therapy has been used to treat a variety of pruriticconditions, although there is a lack of definitive data regarding the efficacyof the therapeutic modality in some of the disorders for which it has beentried, Henry W. Lim, M.D., said at the annual meeting of the American Academyof Dermatology.

New Orleans - New long-term data with the topical immunomodulator tacrolimus(Protopic) and the skin-selective inflammatory cytokine inhibitor pimecrolimus(Elidel) demonstrate efficacy as maintenance therapies in the treatmentof atopic dermatitis in children. Data with pimecrolimus show safety andefficacy for as long as 26 weeks in infants as young as three months, LawrenceEichenfield, M.D., said at the annual meeting of the American Academy ofDermatology.

Kenilworth, N.J. - Clarinex, a new systemic drug for treatmentof urticaria (hives), has been approved by the Food and Drug Administration(FDA), according to Schering-Plough, the drug's manufacturer.

Irvine, Calif. - Turf battles over who should administer botulinumtoxin injections erupted within the first month after the April 15 FDA approvalof Botox Cosmetic.

New Orleans - Successful use of anesthesia in pediatric patients requires more than a working knowledge of anesthetics, according to Gail de Imus, M.D.

New Orleans - A standardized patch test allergen now allows dermatologists to improve diagnosis of allergies related to dust mites, according to Christen M. Mowad, M.D.

Previewing what may become routine in a few years, researchers have used genetic profiling to evaluate efficacy and adverse effects of a drug undergoing clinical trials for the treatment of psoriasis.

New Orleans - Topical tazarotene gel 0.1 percent (Tazorac) can improve the appearance of epidermal nevi and may be worthwhile to consider as an effective and generally well-tolerated modality in children with lesions that are large and present in cosmetically important areas, or for patients who do not wish to have surgery,

Many women commit beauty mistakes regularly. Here is a list of commonfoibles and the little fixes that can improve looks.

With vendor's help, you can incorporate simple applications into yourexisting software

Effective staff meetings require purpose, participation

Every day physicians are audited by both Medicare as well as other third-partypayers.

A. It is important to determine exactly what the patient meanswhen they present with the complaint of "breakouts." Most reputablecosmetic companies test their cosmetics and skincare products and can substantiate

Case cohort study finds 30 to 40 percent of women on HRT less likelyto develop leg ulcers

While complications are inevitable for busy surgeons, focusing attentionremoves a lot of risk

New Orleans - The role of UVA radiation in generating a number of diseases is now much better understood, Robert Bissonnette, M.D., said at the annual meeting of the American Academy of Dermatology. "If you go back 10 years, we knew a lot about UVB but little about UVA. Now, we know that it can cause skin cancer in animals," he said.

Increase not due to advances in diagnosis; meets epidemic definition

Theory on cutaneous immune responses led to long-term safety trials and reassuring answer

Study seeks to define metastatic risk factors of select patients

General symptoms, pain, burning reduced with reports of only minimal side effects

New Orleans - Following treatment with IV- or IM-administered alefacept (Amevive), more than 1,000 patients with chronic plaque psoriasis showed insignificant levels of drug-related antibody.